Evaluation of CD38 as target for immunotherapy in multiple myeloma [letter; comment]

Authors:
  • WVWc Vooijs
    Wc Vooijs
  • HSHj Schuurman
    Hj Schuurman
  • EBEj Bast
    Ej Bast
  • GGGc de Gast
    Gc de Gast

Abstract
No abstract available